Real-World Evidence is Front-and-Center in Alzheimer’s Disease
The recent regulatory decisions for Alzheimer’s disease therapies – including traditional approval for LEQEMBI – are exciting developments but also bring additional requirements from payers. Understanding complex stakeholder requirements and applying them to your real-world evidence strategy early in development is critical to accelerating access for your Alzheimer’s treatment.
Download our complimentary insight brief “Real-World Evidence is Front-and-Center in Alzheimer’s Disease” to understand the evolving landscape and how to start planning for post-marketing requirements in this space.
In this brief, you’ll get full details on:
-
- FDA’s Accelerated Approval Pathway support of Alzheimer’s treatments
-
- Recent drug development and real-world evidence requirements
-
- How to align your real-world evidence strategy and operational approach
Use the form to access the insights from Executive Director, Real-World Evidence Study Solutions Judy Lytle.
Want to know more about us?
Subscribe Now
Want to know more about us?
Subscribe Now
Providers
Thank You for Connecting with UBC
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
What You Can Expect Next
Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.